Relationship Between Vitamin D and Vitamin B12 Levels and Neuropathic Pain in Lipedema
1 other identifier
observational
200
1 country
1
Brief Summary
Lipedema is a disease characterized by bilateral abnormal fat deposition in the upper and lower extremities. Pain is a common symptom in lipedema.Vitamin D plays an important role in chronic pain. Vitamin B have analgesic role in some neuropathic pain conditions.This study aimedto evaluate the relationship between vitamin D and vitamin B12 levels and neuropathic pain in lipedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 23, 2024
CompletedFirst Posted
Study publicly available on registry
March 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedMarch 29, 2024
March 1, 2024
2 months
March 23, 2024
March 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Vitamin B12 Level
Laboratory measurement of patient's vitamin B12 level in unit of pg/mL
1 day
25 OH Vitamin D Level
Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl
1 day
Study Arms (2)
painDETECT questionnaire scores> 13 likely or possible neuropathic pain (group 1)
lipedema patients showing NP symptoms
painDETECT questionnaire scores13 unlikely neuropathic pain(group 2)
lipedema patients showing no NP symptoms
Interventions
Vitamin B12 Level Laboratory measurement of patient's vitamin B12 level in unit of pg/mL 25 OH Vitamin D Level Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl
Eligibility Criteria
lipedema patients
You may qualify if:
- The patients diagnosed byan experienced physical medicine and rehabilitation specialist for the diagnosis of lipedema
You may not qualify if:
- individuals who did not have 25(OH)D and B12 values in the past 6 months,
- those with a history of gastrectomy or bypass surgery,
- those consuming a vegetarian diet, those with lymphedema or chronic venous insufficiency, endocrine diseases, rheumatic diseases, malignancy, neurological diseases, and musculoskeletaldiseases that can be related to lower extremity neuropathic or nociceptivepain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulcan Ozturk
Istanbul, 34752, Turkey (Türkiye)
Related Publications (3)
Poojari A, Dev K, Rabiee A. Lipedema: Insights into Morphology, Pathophysiology, and Challenges. Biomedicines. 2022 Nov 30;10(12):3081. doi: 10.3390/biomedicines10123081.
PMID: 36551837RESULTKiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a neuroactive substance: review. ScientificWorldJournal. 2006 Jan 26;6:125-39. doi: 10.1100/tsw.2006.25.
PMID: 16493517RESULTGharibpoor F, Ghavidel-Parsa B, Sattari N, Bidari A, Nejatifar F, Montazeri A. Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC Rheumatol. 2022 Sep 1;6(1):51. doi: 10.1186/s41927-022-00282-y.
PMID: 36045399RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2024
First Posted
March 29, 2024
Study Start
March 1, 2024
Primary Completion
May 1, 2024
Study Completion
June 1, 2024
Last Updated
March 29, 2024
Record last verified: 2024-03